Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Tortoise

Congress Small Cap Growth Fund Institutional Class (CSMCX)

Ticker CSMCX · · Holdings as of Jul 31, 2026

Expense ratio
1.01%$101/yr per $10k
5-yr return
+9.7%annualized
1-yr return
+8.3%as of Dec 2025
Net assets
$2.0Ball share classes
Holdings
41

Bottom line

Is CSMCX a good fund? The bottom line

CSMCX is the Institutional Class share class of Congress Small Cap Growth Fund, a managed small-cap mutual fund from Tortoise.

Its expense ratio is 1.01% — about $101 a year on every $10,000 invested, more expensive than 54% of small-cap funds we track.

It returned +8.3% over one year, +9.7% a year over five years, +13.6% a year over ten (as of Dec 31, 2025, per its prospectus).

With $2.0 billion in net assets and 41 holdings, its largest position is Ligand Pharmaceuticals Inc (3.9%) and the top 10 make up 32.7% of the portfolio.

What stands out

  • 5-year return beat 79% of category peers

Updated Nov 19, 2026

What CSMCX invests in

The Congress Small Cap Growth Fund (the Small Cap Fund or Fund) seeks long-term capital growth.

The Small Cap Fund seeks to achieve its investment objective by investing at least 80% of its net assets (plus any borrowings for investment purposes) in the common stocks of small-capitalization companies. The Small Cap Fund defines small-capitalization companies as those companies with market capitalizations not exceeding the highest market capitalization in the Russell 2000 Growth Index during the preceding 12 months. As of the last reconstitution date, June 30, 2025, the market capitalization of companies in the Russell 2000 Growth Index ranged from $60.55 million to $15.72 billion. The Fund may invest any portion of the remaining 20% of its net assets in the equity securities of companies with market capitalizations that may be higher or lower than the range of issuer market capitalizations represented in the Russell 2000 Growth Index. The Small Cap Fund may invest in companies…

From the fund's prospectus (filed Feb 27, 2026).

CSMCX performance

Fund calendar-year total returns, 2016–2024 2016: +22.3%; 2017: +2.4%; 2018: +25.0%; 2019: +39.2%; 2020: +39.4%; 2021: −26.2%; 2022: +20.3%; 2023: +18.7%; 2024: +8.3% +22% 2016 +2% 2017 +25% 2018 +39% 2019 +39% 2020 −26% 2021 +20% 2022 +19% 2023 +8% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
CSMCX+8.3%+9.7%+13.6%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full CSMCX performance history →

What CSMCX costs

On a $10,000 investment, CSMCX's 1.01% expense ratio costs about $101 a year. The prospectus estimates $1,236 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full CSMCX fee table →

CSMCX top 10 holdings

#Holding% of fund
1Ligand Pharmaceuticals Inc LGND3.89%
2Moog Inc MOG/A3.69%
3TG Therapeutics Inc TGTX3.37%
4Brinker International Inc EAT3.35%
5Modine Manufacturing Co MOD3.30%
6IMAX Corp IMAX3.10%
7Enpro Inc NPO3.05%
8InterDigital Inc IDCC3.03%
9LivaNova PLC LIVN2.99%
10Sensient Technologies Corp SXT2.89%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 32.7% of the fund. See all top 25 holdings and asset mix →

Alternatives to CSMCX

More funds like CSMCX →

CSMCX FAQ

What is the expense ratio of CSMCX?
CSMCX's expense ratio is 1.01%, which works out to about $101 a year for every $10,000 invested. The prospectus estimates total costs of $1,236 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is CSMCX a good investment?
It depends on your goals, but the data points to: 5-year return beat 79% of category peers. This is general information, not personalized advice.
What does CSMCX hold?
CSMCX's largest holdings are Ligand Pharmaceuticals Inc (3.9%), Moog Inc (3.7%), TG Therapeutics Inc (3.4%), Brinker International Inc (3.4%), Modine Manufacturing Co (3.3%). It holds 41 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is CSMCX's 5-year return?
CSMCX returned +9.7% a year over the five years ending Dec 31, 2025, and +13.6% a year over ten years. Past performance does not guarantee future results.
Who manages CSMCX?
CSMCX is offered by Tortoise through Professionally Managed Portfolios.